A pharmaceutical company focused on non‑opioid pain management therapies used primarily in surgical and musculoskeletal settings. Its flagship product, Exparel, is a long‑acting local anesthetic widely used for postsurgical pain control, with additional products and pipeline candidates targeting ort...
4 members of Congress have disclosed 19 trades in Pacira BioSciences, Inc. (PCRX), a Healthcare company. The buy/sell breakdown shows 17 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-31 | Bradley S. Schneider | buy | $1K – $15K |
| 2021-05-06 | Tom Malinowski | buy | $1K – $15K |
| 2021-04-20 | Tom Malinowski | buy | $1K – $15K |
| 2021-01-25 | Tom Malinowski | buy | $1K – $15K |
| 2021-01-15 | Tom Malinowski | buy | $1K – $15K |
| 2020-11-02 | Tom Malinowski | buy | $1K – $15K |
| 2019-09-26 | Tom Malinowski | buy | $15K – $50K |
| 2019-08-23 | Tom Malinowski | buy | $1K – $15K |
| 2019-06-03 | Tom Malinowski | buy | $15 – $50 |
| 2019-05-31 | Tom Malinowski | buy | $15K – $50K |
| 2019-05-31 | Tom Malinowski | buy | $15K – $50K |
| 2019-05-30 | Tom Malinowski | buy | $15K – $50K |
| 2017-01-13 | JAMES B. RENACCI | buy | $1K – $15K |
| 2016-12-13 | JAMES B. RENACCI | buy | $1K – $15K |
| 2016-10-05 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-04-17 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-11-09 | JAMES B. RENACCI | buy | $15K – $50K |
| 2015-07-20 | JAMES B. RENACCI | sell | $15K – $50K |
| 2015-04-17 | JAMES B. RENACCI | buy | $15K – $50K |